Clinical Trial Update: A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) [Phase 3]

View source ↗

Summary

A Phase 3 study CELESTIAL-RRCLL is evaluating progression-free survival with Sonrotoclax in combination with Obinutuzumab or Rituximab, versus Venetoclax plus R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Obinutuzumab (obinutuzumab)
• Rituximab (rituximab)
• Sonrotoclax
• Venetoclax (venetoclax)

Snippet

Sponsor: BeOne Medicines | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 3 | Status: RECRUITING